The Multiple Myeloma Treatment Simulator
Sharpen your skills in the Multiple Myeloma (MM) Treatment Simulator! Its an innovative approach to CME/CNE. Youll acquire state-of-the art knowledge of MM management by treating virtual patients with highly realistic presentations of MM and associated conditions. You work in a risk free environment and get valuable feedback on each treatment decision you make.
The MM simulator was developed through collaboration between the National Comprehensive Cancer Network (NCCN) and Syandus Inc. The NCCN designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credit(s) and a maximum of 3.0 contact hours for continuing nursing education. CME/CE information is provided within the application.
This activity is supported by educational grants from CELGENE CORPORATION; Novartis Oncology; Takeda Oncology and by a grant from Onyx Pharmaceuticals.
About MM Treatment Simulator:
Absolutely FREE no cost to download, no in-app purchases
Designed for oncologists, nurses, and other health care professionals who manage patients with multiple myeloma
All content is based on NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) with significant input from renowned medical hematologist-oncologists
Provides a powerful experience-based learning environment where you devise a treatment plan and select therapies based on virtual patient needs
Each treatment decision you make is accompanied by intelligent feedback that helps pinpoint clinical nuances of available treatment options and efficiently improve your MM management skills as a whole
You learn about state-of-the-art MM management from experts but at your own pace and in a stress-free environment
NCCN and Syandus respect your privacy and confidentiality. The privacy statement for this activity is available from within the application.
Simple, one touch interaction throughout the app
Multiple interactive areas that are explored to discover information on cases, treatments and other clinically relevant components, including NCCN recommended treatment guidelines
Features 7 highly realistic scenarios that cover diverse multiple myeloma presentations, including stem cell transplant eligible and ineligible, newly diagnosed and relapsed myeloma patients with a wide range of associated conditions
Scenarios can be reworked multiple times
Questions? Comments? Concerns? Go to http://www.alivemed.com/Support